Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. The company's portfolio is primarily centered on central nervous system (CNS) disorders, immunology, and infectious diseases. Tonix's lead candidate, Tonmya (TNX-102 SL), has successfully completed Phase 3 trials for the management of fibromyalgia and is currently under FDA review for a New Drug Application. Additionally, the company is advancing a robust pipeline that includes biologics for organ transplant rejection and live virus vaccines for infectious diseases like smallpox and mpox.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tonix Medicines.